Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy.
Hardwick NR, Frankel P, Ruel C, Kilpatrick J, Tsai W, Kos F, Kaltcheva T, Leong L, Morgan R, Chung V, Tinsley R, Eng M, Wilczynski S, Ellenhorn JDI, Diamond DJ, Cristea M. Hardwick NR, et al. Among authors: tsai w. Clin Cancer Res. 2018 Mar 15;24(6):1315-1325. doi: 10.1158/1078-0432.CCR-17-2709. Epub 2018 Jan 4. Clin Cancer Res. 2018. PMID: 29301826 Free PMC article. Clinical Trial.
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
La Rosa C, Longmate J, Martinez J, Zhou Q, Kaltcheva TI, Tsai W, Drake J, Carroll M, Wussow F, Chiuppesi F, Hardwick N, Dadwal S, Aldoss I, Nakamura R, Zaia JA, Diamond DJ. La Rosa C, et al. Among authors: tsai w. Blood. 2017 Jan 5;129(1):114-125. doi: 10.1182/blood-2016-07-729756. Epub 2016 Oct 19. Blood. 2017. PMID: 27760761 Free PMC article. Clinical Trial.
Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.
Israyelyan A, La Rosa C, Tsai W, Kaltcheva T, Srivastava T, Aquino L, Li J, Kim Y, Palmer J, Streja L, Senitzer D, Zaia JA, Rosenwald A, Forman SJ, Nakamura R, Diamond DJ. Israyelyan A, et al. Among authors: tsai w. Leuk Lymphoma. 2013 Nov;54(11):2490-9. doi: 10.3109/10428194.2013.783910. Epub 2013 Apr 30. Leuk Lymphoma. 2013. PMID: 23480492 Free PMC article.
Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host disease.
Salhotra A, Talley M, Wu X, Tsai W, Mokhtari S, Qin H, Al-Malki MM, Aldoss I, Modi B, Koller P, Kopp E, Smith E, Pawlowska A, Nakamura R. Salhotra A, et al. Among authors: tsai w. Bone Marrow Transplant. 2022 Jun;57(6):1045-1047. doi: 10.1038/s41409-022-01671-0. Epub 2022 Apr 19. Bone Marrow Transplant. 2022. PMID: 35440803 No abstract available.
Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide.
Al Malki MM, Palmer J, Tsai NC, Mokhtari S, Hui S, Tsai W, Aldoss I, Ali H, Aribi A, Cao T, Mei M, Sandhu KS, Siddiqi T, Forman SJ, Nakamura R, Marcucci G, Stein A, Wong JYC, Rosenthal J. Al Malki MM, et al. Among authors: tsai nc, tsai w. Blood Adv. 2022 Jul 26;6(14):4098-4106. doi: 10.1182/bloodadvances.2022007264. Blood Adv. 2022. PMID: 35838754 Free PMC article. Clinical Trial.
Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant.
Al Malki MM, Tsai NC, Palmer J, Mokhtari S, Tsai W, Cao T, Ali H, Salhotra A, Arslan S, Aldoss I, Karras N, Karanes C, Zain J, Khaled S, Stein A, Snyder D, Marcucci G, Forman SJ, Nakamura R. Al Malki MM, et al. Among authors: tsai nc, tsai w. Blood Adv. 2021 Jun 22;5(12):2650-2659. doi: 10.1182/bloodadvances.2021004192. Blood Adv. 2021. PMID: 34156440 Free PMC article. Clinical Trial.
3,388 results